Abstract:Background: Apolipoprotein E (APOE) is the strongest genetic risk factor for sporadic Alzheimer's Disease (AD), and the ε4 allele (APOE4) may interact with lifestyle factors that relate to brain structural changes, underlying the increased risk of AD. However, the exact role of APOE4 in mediating interactions between the peripheral circulatory system and the central nervous system, and how it may link to brain and cognitive aging requires further elucidation. In this analysis, we investigated the association between APOE4 carrier status and multimodal biomarkers (diet, blood markers, clinical diagnosis, brain structure, and cognition) in the context of gene–environment interactions. Methods: Participants were older adults from a longitudinal observational study, the Boston Puerto Rican Health Study (BPRHS), who self-identified as of Puerto Rican descent. Demographics, APOE genotype, diet, blood, and clinical data were collected at baseline and at approximately 12th year, with the addition of multimodal brain magnetic resonance imaging (MRI) (T1-weighted and diffusion) and cognitive testing acquired at 12-year. Measures were compared between APOE4 carriers and non-carriers, and associations between multimodal variables were examined using correlation and multivariate network analyses within each group. Results: A total of 156 BPRHS participants (mean age at imaging = 68 years, 77% female, mean follow-up 12.7 years) with complete multimodal data were included in the current analysis. APOE4 carriers ( n = 43) showed reduced medial temporal lobe (MTL) white matter (WM) microstructural integrity and lower mini-mental state examination (MMSE) score than non-carriers ( n = 113). This pattern was consistent with an independent sample from the Alzheimer's Disease Neuroimaging Initiative (ADNI) of n = 283 non-Hispanic White adults without dementia (mean age = 75, 40% female). Within BPRHS, carriers showed distinct connectivity patterns between multimodal biomarkers, characterized by stronger direct network connections between baseline diet/blood markers with 12-year blood/clinical measures, and between blood markers (especially lipids and cytokines) and WM. Cardiovascular burden (i.e., hypertension and diabetes status) was associated with WM integrity for both carriers and non-carriers. Conclusion: APOE4 carrier status affects interactions between dietary factors, multimodal blood biomarkers, and MTL WM integrity across ~12 years of follow-up, which may reflect increased peripheral-central systems crosstalk following blood–brain barrier breakdown in carriers.

ASSOCIATION BETWEEN APOE-ε4 CARRIER STATUS AND QUALITATIVE NEUROIMAGING CHARACTERISTICS IN OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT.

Association Between Hippocampus, Thalamus, and Caudate in Mild Cognitive Impairment APOEε4 Carriers: A Structural Covariance MRI Study

Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE Ɛ4 Carriers: A Preliminary Study

IC-P-060: Decreased Intrinsic Functional Network in Cognitively Intact Elderly APOE-E4 Carriers Measured by Eigenvector Centrality Mapping

DECREASED INTRINSIC FUNCTIONAL NETWORK IN COGNITIVELY INTACT ELDERLY APOE-E4 CARRIERS MEASURED BY EIGENVECTOR CENTRALITY MAPPING

Associations Between APOE Genotype and Cerebral Small-Vessel Disease: a Longitudinal Study

Affect of APOE on Information Processing Speed in Non-Demented Elderly Population: a Preliminary Structural MRI Study

Altered Effective Connectivity Anchored in the Posterior Cingulate Cortex and the Medial Prefrontal Cortex in Cognitively Intact Elderly APOE Ε4 Carriers: a Preliminary Study

Differences in Grey Matter Concentrations and Functional Connectivity between Young Carriers and Non-Carriers of the APOE ε4 Genotype

P1‐423: THE EFFECTS OF APOE EPSILON4 ALLELES ON COGNITIVE FUNCTION AND RESTING STATE FUNCTIONAL MRI IN PATIENTS WITH AMNESTIC MILD COGNITIVE IMPAIRMENT: A PROSPECTIVE COHORT STUDY

APOE Ε4 Allele Accelerates Age-Related Multi-Cognitive Decline and White Matter Damage in Non-Demented Elderly.

Precuneus Degeneration in Nondemented Elderly Individuals with APOE Ɛ4: Evidence from Structural and Functional MRI Analyses

Association of White Matter Integrity and Cognitive Functions in Chinese Non-Demented Elderly with the APOE Ɛ4 Allele

Impact of APOE ε4 Carrier Status on Associations Between Subthreshold, Positive Amyloid-β Deposition, Brain Function, and Cognitive Performance in Cognitively Normal Older Adults: A Prospective Study

Cortical Thickness and Microstructural White Matter Changes Detect Amnestic Mild Cognitive Impairment.

Disrupted Brain Structural Connectivity: Pathological Interactions Between Genetic APOE ε4 Status and Developed MCI Condition

The Role of MRI Biomarkers and Their Interactions with Cognitive Status and APOE Ε4 in Nondemented Elderly Subjects

Apolipoprotein E4 effects on topological brain network organization in mild cognitive impairment

Neuropsychiatric symptoms and ApoE genotype in older adults without dementia: a cross‐sectional study

APOE4 allele-specific associations between diet, multimodal biomarkers, and cognition among Puerto Rican adults in Massachusetts

Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment.